The law offices of frank r. cruz announces investigation of lifecore biomedical, inc. (lfcr) on behalf of investors

Los angeles--(business wire)--the law offices of frank r. cruz announces an investigation of lifecore biomedical, inc. (“lifecore” or the “company”) (nasdaq: lfcr) on behalf of investors concerning the company's possible violations of federal securities laws. if you are a shareholder who suffered a loss, click here to participate. on march 20, 2024, lifecore filed restated financial statements for fiscal year 2021 and 2022 to “correct errors involving the calculation of capitalized interest, va.
LFCR Ratings Summary
LFCR Quant Ranking